Risk factors for rectal colonization with vancomycin-resistant enterococci in Shiraz, Iran

International Journal of Infectious Diseases

Volumn 12, Issue 2, 2008, Pages 171-175

  Askarian, Mehrdad ^a   Afkhamzadeh, Rahim ^a   Monabbati, Ahmad ^a   Daxboeck, Florian ^b   Assadian, Ojan ^b  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Enterococcus; Rectal colonization; Risk factors; Vancomycin resistance; VRE

Indexed keywords

ANTIBIOTIC AGENT; CEPHALOSPORIN; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; CASE CONTROL STUDY; CHILD; ENTEROCOCCAL INFECTION; ENTEROCOCCUS; FEASIBILITY STUDY; FEMALE; HEMODIALYSIS; HUMAN; INTERVENTION STUDY; IRAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREVALENCE; RISK FACTOR; UNIVARIATE ANALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; ENTEROCOCCUS; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HOSPITAL DEPARTMENTS; HUMANS; INFANT; INFANT, NEWBORN; IRAN; LOGISTIC MODELS; MALE; MIDDLE AGED; PREVALENCE; RECTUM; RISK FACTORS; VANCOMYCIN RESISTANCE;

EID: 39049088552     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2007.04.020     Document Type: Article

References (31)

1. Tornieporth N.G., Roberts R.B., John J., Hafner A., and Riley L.W. Risk factors associated with vancomycin-resistant Enterococcus faecium infection or colonization in 145 matched case patients and control patients. Clin Infect Dis 23 (1996) 767-772
2. Bonten M.J., Willems R., and Weinstein R.A. Vancomycin-resistant enterococci: why are they here, and where do they come from?. Lancet Infect Dis 1 (2001) 314-325
3. Endtz H.P., van den Braak N., Verbrugh H.A., and Van Belkum A. Vancomycin resistance: status quo and quo vadis. Eur J Clin Microbiol Infect Dis 18 (1999) 683-690
4. DeLisle S., and Perl T.M. Vancomycin-resistant enterococci: a road map on how to prevent the emergence and transmission of antimicrobial resistance. Chest 123 5 Suppl (2003) 504S-518S
5. Bertrand X., Thouverez M., Bailly P., Cornette C., and Talon D. Clinical and molecular epidemiology of hospital Enterococcus faecium isolates in eastern France. J Hosp Infect 45 (2000) 125-134
6. Dan M., Poch F., Leibson L., Smetana S., and Priel I. Rectal colonization with vancomycin-resistant enterococci among high-risk patients in an Israeli hospital. J Hosp Infect 43 (1999) 231-238
7. Ford M., Perry J.D., and Gould F.K. Use of cephalexin-aztreonam-arabinose agar for selective isolation of Enterococcus faecium. J Clin Microbiol 32 (1994) 2999-3001
8. Facklam R.R. Recognition of group D streptococcal species of human origin by biochemical and physiological tests. J Clin Microbiol 23 (1972) 1131-1139
9. Facklam R.R., and Collins M.D. Identification of Enterococcus species isolated from human infections by a conventional test scheme. J Clin Microbiol 27 (1989) 731-734
10. National Committee of Clinical and Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Fourteenth Informational Supplement. NCCLS document M2-A8 and M7-A6. Villanova, Pennsylvania: NCCLS; 2004.
11. Rothman K.J. Modern epidemiology (1986), Little, Brown & Co., Boston, USA p. 285-311
12. Beltrami E.M., Singer D.A., Fish L., Manning K., Young S., Banerjee S.N., et al. Risk factors for acquisition of vancomycin-resistant enterococci among patients on a renal ward during a community hospital outbreak. Am J Infect Control 28 (2000) 282-285
13. Snell J.J., Brown D.F., Perry S.F., and George R. Antimicrobial susceptibility testing of enterococci: results of a survey conducted by the United Kingdom National External Quality Assessment Scheme for Microbiology. J Antimicrobial Chemother 32 (1993) 401-411
14. Jones R.N., Sader H.S., Erwin M.E., and Anderson S.C. Emerging multiply resistant enterococci among clinical isolates. I. Prevalence data from 97 medical center surveillance study in the United States. Enterococcus Study Group. Diagn Microbiol Infect Dis 21 (1995) 85-93
15. Mellmann A., Orth D., Dierich M.P., Allerberger F., Klare I., and Witte W. Nosocomial cross transmission as a primary cause of vancomycin-resistant enterococci in Austria. J Hosp Infect 44 (2000) 281-287
16. Bhavnani S.M., Drake J.A., Forrest A., Deinhart J.A., Jones R.N., Biedenbach D.J., et al. A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia. Diagn Microbiol Infect Dis 36 (2000) 145-158
17. Edmond M.B., Ober J.F., Dawson J.D., Weinbaum D.L., and Wenzel R.P. Vancomycin-resistant enterococcal bacteremia: natural history and attributable mortality. Clin Infect Dis 23 (1996) 1234-1239
18. Linden P.K., Pasculle A.W., Manez R., Kramer D.J., Fung J.J., Pinna A.D., et al. Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium. Clin Infect Dis 22 (1996) 663-670
19. Lucas G.M., Lechtzin N., Puryear D.W., Yau L.L., Flexner C.W., and Moore R.D. Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes. Clin Infect Dis 26 (1998) 1127-1133
20. D'Agata E.M., Green W.K., Schulman G., Li H., Tang Y.W., and Schaffner W. Vancomycin-resistant enterococci among chronic hemodialysis patients: a prospective study of acquisition. Clin Infect Dis 32 (2001) 23-29
21. Loeb M., Salama S., Armstrong-Evans M., Capretta G., and Olde J. A case-control study to detect modifiable risk factors for colonization with vancomycin-resistant enterococci. Infect Control Hosp Epidemiol 20 (1999) 760-763
22. Zaas A.K., Song X., Tucker P., and Perl T.M. Risk factors for development of vancomycin-resistant enterococcal bloodstream infection in patients with cancer who are colonized with vancomycin-resistant enterococci. Clin Infect Dis 35 (2002) 1139-1146
23. Schouten M.A., Hoogkamp-Korstanje J.A., Meis J.F., and Voss A. Prevalence of vancomycin-resistant enterococci in Europe. Eur J Clin Microbiol Infect Dis 19 (2000) 816-822
24. Singh-Naz N., Sleemi A., Pikis A., Patel K.M., and Campos J.M. Vancomycin-resistant Enterococcus faecium colonization in children. J Clin Microbiol 37 (1999) 413-416
25. van den Braak N., Ott A., van Belkum A., Kluytmans J.A., Koeleman J.G., Spanjaard L., et al. Prevalence and determinants of fecal colonization with vancomycin-resistant Enterococcus in hospitalized patients in The Netherlands. Infect Control Hosp Epidemiol 21 (2000) 520-524
26. Antalek M.D., Mylotte J.M., Lesse A.J., and Sellick Jr. J.A. Clinical and molecular epidemiology of Enterococcus faecalis bacteremia, with special reference to strains with high-level resistance to gentamicin. Clin Infect Dis 20 (1995) 103-109
27. Fridkin S.K., Edwards J.R., Courval J.M., Hill H., Tenover F.C., Lawton R., et al. The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 U.S. adult intensive care units. Ann Intern Med 135 (2001) 175-183
28. Sofianou D., Pournaras S., Giosi M., Polyzou A., Maniatis A.N., and Tsakris A. Substantially increased faecal carriage of vancomycin-resistant enterococci in a tertiary Greek hospital after a 4 year time interval. J Antimicrob Chemother 54 (2004) 251-254
29. Baran Jr. J., Riederer K.M., Ramanathan J., and Khatib R. Recurrent vancomycin-resistant Enterococcus bacteremia: prevalence, predisposing factors, and strain relatedness. Clin Infect Dis 32 (2001) 1381-1383
30. Barbosa D., Lima L., Silbert S., Sader H., Cendoroglo M., Draibe S., et al. Evaluation of the prevalence and risk factors for colonization by vancomycin-resistant Enterococcus among patients on dialysis. Am J Kidney Dis 44 (2004) 337-343
31. MacIntyre C.R., Empson M., Boardman C., Sindhusake D., Lokan J., and Brown G.V. Risk factors for colonization with vancomycin-resistant enterococci in a Melbourne hospital. Infect Control Hosp Epidemiol 22 (2001) 624-649